Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • AMYLIN PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 816.84 M 1.13 B 767.33 M 443.42 M 293.76 M
    Net Receivables 66.05 M 79.41 M 62.98 M 30.17 M 7.08 M
    Total Inventories 115.82 M 100.21 M 59.30 M 26.75 M 15.68 M
    Progress Payments & Others 0.00 -400,000.00 -1.60 M -3.10 M -3.34 M
    Prepaid Expenses 30.34 M 15.79 M 17.21 M 14.46 M 7.84 M
    Other Current Assets 7.02 M 10.48 M 0.00 0.00 0.00
    Current Assets Total 1.04 B 1.34 B 906.82 M 514.80 M 324.36 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 4.70 M 15.70 M 0.00 0.00 0.00
    Other Investments 0.00 0.00 0.00 0.00 0.00
    Property, Plant & Equipment Net 636.92 M 390.30 M 146.78 M 42.05 M 20.74 M
    Property, Plant & Equipment Gross 720.87 M 438.82 M 177.24 M 60.66 M 31.50 M
    Accumulated Depreciation 83.95 M 48.52 M 30.46 M 18.61 M 10.76 M
    Other Assets 34.94 M 31.90 M 6.79 M 11.19 M 12.70 M
    Deferred Charges 15.88 M 19.52 M 3.92 M 7.50 M 9.44 M
    Tangible Other Assets 16.16 M 9.68 M 0.00 0.00
    Intangible Other Assets 2.90 M 2.70 M 2.87 M 3.69 M 3.26 M
    Total Assets 1.71 B 1.77 B 1.06 B 568.05 M 357.80 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 31.25 M 0.00 0.00 14,000.00 13,000.00
    Accrued Payroll 65.14 M 56.43 M 39.25 M 29.12 M 13.51 M
    Income Taxes Payable
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 177.92 M 193.33 M 127.80 M 49.49 M 8.28 M
    Current Liabilities Total 313.78 M 287.28 M 203.89 M 99.67 M 41.94 M
    Long Term Debt 868.75 M 900.00 M 200.00 M 375.00 M 375.00 M
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 125.00 M 11.79 M 12.87 M 16.76 M 20.94 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 54.23 M 22.32 M 8.34 M 7.35 M 7.29 M
    Total Liabilities 1.36 B 1.22 B 425.10 M 498.78 M 445.17 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 350.87 M 552.82 M 635.29 M 69.26 M -87.37 M
    Common Stock 138,000.00 135,000.00 130,000.00 111,000.00 94,000.00
    Capital Surplus 2.11 B 1.99 B 1.86 B 1.07 B 710.46 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves -162,000.00 -310,000.00 -443,000.00
    Unappropriated (Free) Reserves 0.00 0.00 0.00
    Retained Earnings -1.75 B -1.43 B -1.22 B -1.00 B -797.50 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities -11.01 M -450,000.00 1.15 M -467,000.00 -263,000.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 1.71 B 1.77 B 1.06 B 568.05 M 357.80 M
    Common Shares Outstanding 137.62 M 135.04 M 130.46 M 110.53 M 94.49 M